Eišiškių šeimos medicinos centras, UAB - financials and debts
Company age: 18 y. 0 mo.
Eišiškių šeimos medicinos centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 219,400 | 260,753 | 292,782 | 340,856 | 392,973 | 474,970 | 539,011 | 586,788 |
| Profit before tax | 229 | 5,304 | 4,583 | 6,279 | 76 | 11,020 | 209 | 0 |
| Net profit | 229 | 5,304 | 4,583 | 6,279 | 76 | 11,020 | 209 | 0 |
| Equity | 22,235 | 27,539 | 32,450 | 33,818 | 34,805 | 61,344 | 61,553 | 56,968 |
| Liabilities | 64,127 | 49,395 | 45,646 | 54,730 | 2,349 | 12,063 | 19,258 | 14,231 |
| Non-current assets | 55,719 | 47,028 | 35,357 | 29,391 | 17,511 | 5,844 | 6,126 | 16,667 |
| Current assets | 30,643 | 29,906 | 41,839 | 59,157 | 55,232 | 67,563 | 72,905 | 65,481 |
| Total assets | 86,362 | 76,934 | 77,196 | 88,548 | 72,743 | 73,407 | 79,031 | 82,148 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 72,195 | 72,561 | 86,266 |
| Social insurance contributions | - | - | - | - | - | 91,065 | 103,552 | 115,763 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +12.9% | +18.8% | +12.3% | +16.4% | +15.3% | +20.9% | +13.5% | +8.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.3% | 6.9% | 5.9% | 7.1% | 0.1% | 15.0% | 0.3% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 1.0% | 19.3% | 14.1% | 18.6% | 0.2% | 18.0% | 0.3% | 0.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.1% | 2.0% | 1.6% | 1.8% | 0.0% | 2.3% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.1% | 2.0% | 1.6% | 1.8% | 0.0% | 2.3% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.9 | 1.8 | 1.4 | 1.6 | 0.1 | 0.2 | 0.3 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 14,791 | 17,481 | 17,567 | 20,554 | 24,561 | 28,498 | 30,655 | 31,862 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Eišiškių šeimos medicinos centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-16 | 2026-07-17 | 763.03 |
| 2026-03-27 | 2026-03-27 | 10.35 |
| 2026-03-17 | 2026-03-18 | 10.35 |
| 2025-01-16 | 2025-01-20 | 3456.04 |
| 2024-11-18 | 2024-11-19 | 4864.78 |
| 2024-10-16 | 2024-10-20 | 764.02 |
| 2024-07-16 | 2024-07-17 | 1958.61 |
| 2022-08-11 | 2022-08-22 | 604.83 |
| 2022-08-01 | 2022-08-10 | 6024.83 |
| 2022-07-18 | 2022-07-20 | 6024.83 |
Eišiškių šeimos medicinos centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-11-12 | 2025-11-12 | 6735.88 |
| 2025-05-17 | 2025-06-02 | 45.4 |
| 2025-05-11 | 2025-05-16 | 30.79 |
| 2025-05-01 | 2025-05-10 | 31.86 |
| 2025-04-30 | 2025-04-30 | 16.02 |
| 2025-04-08 | 2025-04-08 | 7338.3 |
| 2025-03-20 | 2025-03-26 | 17.61 |
| 2025-03-05 | 2025-03-06 | 6139.76 |
| 2024-12-22 | 2024-12-27 | 0.48 |
| 2024-12-21 | 2024-12-21 | 23.4 |
| 2024-12-19 | 2024-12-20 | 902.9 |
| 2024-12-18 | 2024-12-18 | 902.66 |
| 2024-12-17 | 2024-12-17 | 5779.57 |
| 2024-11-17 | 2024-11-23 | 6372.66 |
| 2024-10-15 | 2024-10-16 | 5723.95 |
| 2024-10-12 | 2024-10-14 | 5700.97 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Eišiškiu šeimos medicinos centras, UAB (code 301856751) is a Private Limited Liability Company engaged in general medical practice activities. In 2025, the company generated revenue of €586.8K, up 8.9% year on year and 23.5% compared with 2023. The revenue trend has therefore been steadily positive over the last three years, increasing from €475.0K in 2023 to €539.0K in 2024 and further in 2025. Profitability weakened materially after 2023: net profit was €11.0K in 2023, then fell to €209 in 2024, while 2025 net profit was not provided. As a result, the business operated with very thin profit generation in 2024. The balance sheet remained stable, with total assets rising from €73.4K in 2023 to €79.0K in 2024 and €82.1K in 2025. Equity stood at €57.0K in 2025, with liabilities of €14.2K. Key indicators point to a solid capital structure, including an equity ratio of 69.3%, debt-to-equity of 0.25, and asset turnover of 7.14x. Revenue per employee was €32.6K.